- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00097799
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
November 29, 2016 updated by: Boehringer Ingelheim
An Open Label, Non-randomized Treatment Protocol of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Protease Inhibitor-experienced Patients With HIV-1 Infection (the Tipranavir Expanded Access Program)
This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.
Study Overview
Status
Approved for marketing
Conditions
Intervention / Treatment
Study Type
Expanded Access
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Anniston, Alabama, United States
- 1182.70.127 Health Services Center, Inc.
-
-
Arizona
-
Phoenix, Arizona, United States
- 1182.70.006 Spectrum Medical Group
-
-
Arkansas
-
Little Rock, Arkansas, United States
- 1182.70.016 Health for Life Clinic
-
-
California
-
Anaheim, California, United States
- 1182.70.065
-
Baldwin Park, California, United States
- 1182.70.246
-
Fountain Valley, California, United States
- 1182.70.043
-
Fresno, California, United States
- 1182.70.092
-
Glendale, California, United States
- 1182.70.057
-
Harbor City, California, United States
- 1182.70.064
-
Long Beach, California, United States
- 1182.70.079
-
Los Angeles, California, United States
- 1182.70.015
-
Los Angeles, California, United States
- 1182.70.053
-
Los Angeles, California, United States
- 1182.70.066
-
Los Angeles, California, United States
- 1182.70.071
-
Los Angeles, California, United States
- 1182.70.137
-
Los Angeles, California, United States
- 1182.70.198
-
Newport Beach, California, United States
- 1182.70.008
-
Oakland, California, United States
- 1182.70.081
-
Oakland, California, United States
- 1182.70.095
-
Panorama City, California, United States
- 1182.70.067
-
San Diego, California, United States
- 1182.70.033
-
San Francisco, California, United States
- 1182.70.014
-
San Francisco, California, United States
- 1182.70.020
-
San Francisco, California, United States
- 1182.70.048
-
San Francisco, California, United States
- 1182.70.085
-
San Francisco, California, United States
- 1182.70.214
-
San Rafael, California, United States
- 1182.70.022
-
Stanford, California, United States
- 1182.70.222
-
Tarzana, California, United States
- 1182.70.005
-
Tarzana, California, United States
- 1182.70.030
-
Woodland Hills, California, United States
- 1182.70.068
-
-
Colorado
-
Denver, Colorado, United States
- 1182.70.218 Denver Infectious Disease Consultants
-
Denver, Colorado, United States
- 1182.70.281
-
-
Connecticut
-
New Haven, Connecticut, United States
- 1182.70.074
-
Norwich, Connecticut, United States
- 1182.70.073
-
-
District of Columbia
-
Washington, District of Columbia, United States
- 1182.70.032
-
Washington, District of Columbia, United States
- 1182.70.042
-
Washington, District of Columbia, United States
- 1182.70.289 Dupont Circle Physicians Group
-
-
Florida
-
Fort Lauderdale, Florida, United States
- 1182.70.003
-
Fort Lauderdale, Florida, United States
- 1182.70.013
-
Fort Lauderdale, Florida, United States
- 1182.70.049
-
Fort Lauderdale, Florida, United States
- 1182.70.096
-
Fort Myers, Florida, United States
- 1182.70.045
-
Hollywood, Florida, United States
- 1182.70.026
-
Miami, Florida, United States
- 1182.70.023
-
North Palm Beach, Florida, United States
- 1182.70.040
-
Orlando, Florida, United States
- 1182.70.007
-
Plantation, Florida, United States
- 1182.70.117
-
Pompano Beach, Florida, United States
- 1182.70.017
-
West Palm Beach, Florida, United States
- 1182.70.047
-
-
Georgia
-
Atlanta, Georgia, United States
- 1182.70.002
-
Atlanta, Georgia, United States
- 1182.70.046
-
Atlanta, Georgia, United States
- 1182.70.069
-
Dactur, Georgia, United States
- 1182.70.037
-
Jesup, Georgia, United States
- 1182.70.058
-
Macon, Georgia, United States
- 1182.70.174
-
-
Illinois
-
Chicago, Illinois, United States
- 1182.70.019
-
Chicago, Illinois, United States
- 1182.70.029 Dr. David Moore
-
Chicago, Illinois, United States
- 1182.70.194
-
Joliet, Illinois, United States
- 1182.70.010
-
-
Indiana
-
Indianapolis, Indiana, United States
- 1182.70.167
-
-
Iowa
-
Iowa City, Iowa, United States
- 1182.70.192
-
-
Louisiana
-
New Orleans, Louisiana, United States
- 1182.70.099
-
-
Maryland
-
Baltimore, Maryland, United States
- 1182.70.025 Chase Brexton Health Services, Inc
-
-
Massachusetts
-
Boston, Massachusetts, United States
- 1182.70.082
-
Boston, Massachusetts, United States
- 1182.70.090
-
-
Michigan
-
Berkley, Michigan, United States
- 1182.70.004
-
Detroit, Michigan, United States
- 1182.70.084
-
-
Missouri
-
St. Louis, Missouri, United States
- 1182.70.035
-
St. Louis, Missouri, United States
- 1182.70.242
-
-
Nebraska
-
Lincoln, Nebraska, United States
- 1182.70.093
-
-
Nevada
-
Las Vegas, Nevada, United States
- 1182.70.021
-
-
New Jersey
-
Hackensack, New Jersey, United States
- 1182.70.288 Hackensack University Medical Center
-
Sommers Point, New Jersey, United States
- 1182.70.075
-
-
New York
-
Briarcliff Manor, New York, United States
- 1182.70.024
-
Bronk, New York, United States
- 1182.70.105
-
Bronx, New York, United States
- 1182.70.250 Montefiore Medical Center
-
Kingston, New York, United States
- 1182.70.039
-
New York, New York, United States
- 1182.70.028
-
New York, New York, United States
- 1182.70.031
-
New York, New York, United States
- 1182.70.036
-
New York, New York, United States
- 1182.70.050
-
New York, New York, United States
- 1182.70.062
-
New York, New York, United States
- 1182.70.104
-
Rochester, New York, United States
- 1182.70.086 Boehringer Ingelheim Investigational Site
-
-
North Carolina
-
Asheville, North Carolina, United States
- 1182.70.061
-
Chapel Hill, North Carolina, United States
- 1182.70.100
-
Charlotte, North Carolina, United States
- 1182.70.136 Mecklenburg Medical Group, P.A.
-
Durham, North Carolina, United States
- 1182.70.103
-
-
Ohio
-
Cincinnati, Ohio, United States
- 1182.70.241 University of CIncinnati Medical Center
-
-
Oregon
-
Portland, Oregon, United States
- 1182.70.044
-
Portland, Oregon, United States
- 1182.70.059 Fanno Creek Clinic
-
Portland, Oregon, United States
- 1182.70.077 Kaiser Permanente-IDC
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States
- 1182.70.051
-
Philadelphia, Pennsylvania, United States
- 1182.70.080
-
-
Rhode Island
-
Providence, Rhode Island, United States
- 1182.70.072
-
-
South Carolina
-
Charleston, South Carolina, United States
- 1182.70.126
-
Charleston, South Carolina, United States
- 1182.70.271
-
Columbia, South Carolina, United States
- 1182.70.088
-
-
Tennessee
-
Nashville, Tennessee, United States
- 1182.70.165 Comprehensive Care Center
-
-
Texas
-
Austin, Texas, United States
- 1182.70.018
-
Dallas, Texas, United States
- 1182.70.038
-
Dallas, Texas, United States
- 1182.70.041
-
Dallas, Texas, United States
- 1182.70.055
-
Dallas, Texas, United States
- 1182.70.070
-
El Paso, Texas, United States
- 1182.70.060
-
Houston, Texas, United States
- 1182.70.052
-
Houston, Texas, United States
- 1182.70.054
-
Houston, Texas, United States
- 1182.70.285
-
San Antonio, Texas, United States
- 1182.70.128 Olmos Park Medical Associates
-
-
Virginia
-
Annadale, Virginia, United States
- 1182.70.011
-
Richmond, Virginia, United States
- 1182.70.217
-
-
Washington
-
Seattle, Washington, United States
- 1182.70.097
-
Seattle, Washington, United States
- 1182.70.76
-
Spokane, Washington, United States
- 1182.70.083
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2004
Primary Completion (Actual)
August 1, 2005
Study Registration Dates
First Submitted
November 30, 2004
First Submitted That Met QC Criteria
November 30, 2004
First Posted (Estimate)
December 1, 2004
Study Record Updates
Last Update Posted (Estimate)
November 30, 2016
Last Update Submitted That Met QC Criteria
November 29, 2016
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Disease Attributes
- Infections
- Communicable Diseases
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
- Anti-HIV Agents
- Anti-Retroviral Agents
- Protease Inhibitors
- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P-450 Enzyme Inhibitors
- HIV Protease Inhibitors
- Viral Protease Inhibitors
- Ritonavir
- Tipranavir
Other Study ID Numbers
- 1182.70
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CAN Community HealthGilead Sciences; Midway Specialty Care Center; Costello Medical Inc.Not yet recruitingHIV | HIV 1 Infection | HIV -1 Infection | HIV (Human Immunodeficiency Virus)United States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Tipranavir
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Puerto Rico
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimApproved for marketingHIV InfectionsUnited States, Australia, Belgium, Denmark, France, Greece, Ireland, Italy, Portugal, South Africa, Switzerland, United Kingdom
-
Boehringer IngelheimApproved for marketingHIV InfectionsBelgium, Brazil, Canada, Denmark, El Salvador, Greece, Italy, Portugal, Spain
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Italy, Mexico, Netherlands, Portugal, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimTerminatedHIV InfectionsUnited States, Argentina, Brazil, France, Germany, Italy, Spain
-
Boehringer IngelheimCompleted